Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Product

Xcopri

2 clinical trials

1 indication

Indication
Partial Epilepsy
Clinical trial
A Phase I, Open-Label, Pharmacokinetic, Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures
Status: Recruiting, Estimated PCD: 2024-07-01
Clinical trial
Open-Label Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures
Status: Recruiting, Estimated PCD: 2026-05-01